WuXi is first in China with CLIA-OK genomics lab

WuXi PharmaTech ($WX) won Clinical Laboratory Improvement Amendments (CLIA) certification for its Shanghai genomics lab, making it the first such outfit in China to meet U.S. testing standards. With the approval, WuXi is now clear to undertake various clinical trial gene sequencing projects to support U.S.-based development efforts. News

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

Analytica Laser has a novel system which the company touts as the industry's first dynamic tool to predict real-world health outcomes.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.